- Home
- GTIM vs HIND Comparison
GTIM vs HIND Comparison
Compare GTIM & HIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GTIM | HIND |
|---|---|---|
| Founded | 1987 | 2017 |
| Country | United States | United States |
| Employees | 2078 | 2 |
| Industry | Restaurants | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.8M | 15.2M |
| IPO Year | 2013 | 2016 |
Fundamental Metrics
Financial Performance| Metric | GTIM | HIND |
|---|---|---|
| Price | $1.51 | $1.91 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.83 |
| AVG Volume (30 Days) | ★ 37.0K | 16.7K |
| Earning Date | 08-06-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 64.86 |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $142,315,000.00 | $319,714.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $82.65 |
| P/E Ratio | $7.14 | ★ N/A |
| Revenue Growth | 3.01 | ★ 24.43 |
| 52 Week Low | $1.10 | $1.75 |
| 52 Week High | $2.09 | $6.56 |
Technical Indicators
Market Signals| Indicator | GTIM | HIND |
|---|---|---|
| Relative Strength Index (RSI) | 49.70 | 43.14 |
| Support Level | $1.44 | $1.84 |
| Resistance Level | $1.52 | $2.31 |
| Average True Range (ATR) | 0.05 | 0.11 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 42.86 | 22.22 |
Price Performance
Historical ComparisonAbout GTIM Good Times Restaurants Inc.
Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants, which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants, which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers, chicken, frozen custard; slides and drinks.
About HIND Vyome Holdings Inc.
Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.